BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Judd AS, Souers AJ, Wodka D, Zhao G, Mulhern MM, Iyengar RR, Gao J, Lynch JK, Freeman JC, Falls HD, Brodjian S, Dayton BD, Reilly RM, Gintant G, Limberis JT, Mikhail A, Leitza ST, Houseman KA, Diaz G, Bush EN, Shapiro R, Knourek-segel V, Hernandez LE, Marsh KC, Sham HL, Collins CA, Kym PR. Identification of diamino chromone-2-carboxamides as MCHr1 antagonists with minimal hERG channel activity. Bioorganic & Medicinal Chemistry Letters 2007;17:2365-71. [DOI: 10.1016/j.bmcl.2006.11.068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Pandiri M, Nukala SK, Swamy TN, Dasari G, Badithapuram V, Manchal R, Bandari S. Design, Synthesis, and Anticancer Activity of Some New N-{5-[(1H-Benzo[d]imidazol-1-yl)methyl]isoxazol-3-yl}benzamide Hybrids. Russ J Gen Chem 2021;91:2320-6. [DOI: 10.1134/s1070363221110207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Popov AB, Krstulović L, Koštrun S, Jelić D, Bokulić A, Stojković MR, Zonjić I, Taylor MC, Kelly JM, Bajić M, Raić-Malić S. Design, synthesis, antitrypanosomal activity, DNA/RNA binding and in vitro ADME profiling of novel imidazoline-substituted 2-arylbenzimidazoles. Eur J Med Chem 2020;207:112802. [PMID: 32927230 DOI: 10.1016/j.ejmech.2020.112802] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Helal MA, Chittiboyina AG, Avery MA. Identification of a new small molecule chemotype of Melanin Concentrating Hormone Receptor-1 antagonists using pharmacophore-based virtual screening. Bioorg Med Chem Lett 2019;29:126741. [PMID: 31678007 DOI: 10.1016/j.bmcl.2019.126741] [Reference Citation Analysis]
4 Mouselmani R, Hachem A, Alaaeddine A, Métay E, Lemaire M. Reduction of aromatic nitriles into aldehydes using calcium hypophosphite and a nickel precursor. Org Biomol Chem 2018;16:6600-5. [PMID: 30175348 DOI: 10.1039/c8ob01751d] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
5 Guyon C, Métay E, Popowycz F, Lemaire M. Synthetic applications of hypophosphite derivatives in reduction. Org Biomol Chem 2015;13:7879-906. [DOI: 10.1039/c5ob01032b] [Cited by in Crossref: 10] [Article Influence: 1.4] [Reference Citation Analysis]
6 Gaspar A, Matos MJ, Garrido J, Uriarte E, Borges F. Chromone: A Valid Scaffold in Medicinal Chemistry. Chem Rev 2014;114:4960-92. [DOI: 10.1021/cr400265z] [Cited by in Crossref: 374] [Cited by in F6Publishing: 251] [Article Influence: 46.8] [Reference Citation Analysis]
7 Högberg T, Frimurer TM, Sasmal PK. Melanin concentrating hormone receptor 1 (MCHR1) antagonists—Still a viable approach for obesity treatment? Bioorganic & Medicinal Chemistry Letters 2012;22:6039-47. [DOI: 10.1016/j.bmcl.2012.08.025] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
8 Guo D, Klaasse E, de Vries H, Brussee J, Nalos L, Rook MB, Vos MA, van der Heyden MA, Ijzerman AP; Shagufta. Exploring chemical substructures essential for HERG k(+) channel blockade by synthesis and biological evaluation of dofetilide analogues. ChemMedChem 2009;4:1722-32. [PMID: 19725081 DOI: 10.1002/cmdc.200900203] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
9 Ali TE, Ibrahim MA, Abdel-kariem SM. Synthesis of Biologically Active 4-Oxo-4 H -Chromene Derivatives Containing Sulfur-Nitrogen Heterocycles. Phosphorus, Sulfur, and Silicon and the Related Elements 2009;184:2358-92. [DOI: 10.1080/10426500802473094] [Cited by in Crossref: 10] [Article Influence: 0.8] [Reference Citation Analysis]
10 Méndez-andino JL, Wos JA. MCH-R1 antagonists: what is keeping most research programs away from the clinic? Drug Discovery Today 2007;12:972-9. [DOI: 10.1016/j.drudis.2007.08.010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
11 Rokosz LL. Discovery and development of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity. Expert Opinion on Drug Discovery 2007;2:1301-27. [DOI: 10.1517/17460441.2.10.1301] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]